Bharat Immunologicals & Biologicals Corporation Ltd.

Financial

	Bharat Immunological	Ind-Swift	Makers Laboratories
Operational Metrics
Financials
5 yr Average ROE	-29.83 %	13.04 %	-2.27 %
5yr average Equity Multiplier	3.08	-0.95	2.42
5yr Average Asset Turnover Ratio	0.61	0.57	0.68
5yr Avg Net Profit Margin	-18.38 %	-31.25 %	-1.81 %
Price to Book	1.35	0.0	1.29
P/E	0.0	1.44	19.59
5yr Avg Cash Conversion Cycle	206.63 Days	-141.81 Days	81.6 Days
Inventory Days	125.06 Days	64.0 Days	108.24 Days
Days Receivable	61.4 Days	88.62 Days	69.51 Days
Days Payable	117.81 Days	283.86 Days	109.89 Days
5yr Average Interest Coverage Ratio	-2.32	-4.31	3.06
5yr Avg ROCE	-44.64 %	-53.05 %	4.88 %
5yr Avg Operating Profit Margin	-18.7 %	1.75 %	7.75 %
5 yr average Debt to Equity	0.71	-1.52	0.25
5yr CAGR Net Profit	23.51 %	n/a	80.14 %
5yr Average Return on Assets	-10.1 %	-12.25 %	-0.95 %
Shareholdings
Promoter Holding	59.25 %	55.58 %	61.27 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	2.9 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Bharat Immunological	Ind-Swift	Makers Laboratories
Product Wise Break-Up	Product Wise Break-Up Oral Polio Vaccine 100.0 BIBSANIT 0 BIB VIT 0 Zinc Tablets 0 Sales of APIs 0 Services 0 Chemicals 0 Generic Formulation 0	Product Wise Break-Up Zinc Tablets 0 BIB VIT 0 Generic Formulation 0 Oral Polio Vaccine 0 Active Pharmaceutical Ingredient (API) 100.0 BIBSANIT 0 Services 0 Chemicals 0	Product Wise Break-Up Zinc Tablets 0 BIB VIT 0 Formulation 39.53 Oral Polio Vaccine 0 Sales of APIs 0 BIBSANIT 0 Services 7.75 Chemicals 52.71 Others 0.01
Asset Break-Up	Asset Break-Up Oral Polio Vaccine 94.18 Zinc Tablets 0.04 BIB sweets Tablets 0 Chemicals 0 Pharmaceuticals 0 Others 5.78	-	Asset Break-Up Zinc Tablets 0 Pharmaceuticals 33.09 Oral Polio Vaccine 0 Chemicals 66.91 BIB sweets Tablets 0